Dual inhibition of histone deacetylases and phosphoinositide 3-kinase enhances therapeutic activity against B cell lymphoma.
Oncotarget
Mondello, Patrizia P; Derenzini, Enrico E; Asgari, Zahra Z; Philip, John J; Brea, Elliott J EJ; Seshan, Venkatraman V; Hendrickson, Ronald C RC; de Stanchina, Elisa E; Scheinberg, David A DA; Younes, Anas A